McKesson Corporation
MCK
Rankning i aktier
#187
McKesson Corporation is a prominent global provider of healthcare services,... McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
Aktiekurs
$1,029.14
Senast synkroniserad: 2026-10-20
Marknadsvärde
$119.99B
Förändring (1 dag)
1.73%
Förändring (1 år)
30.72%
Land
US
Handel McKesson Corporation (MCK)
Kategori
Healthcare
P/E-tal för McKesson Corporation (MCK)
P/E-tal per October 2026 TTM: 26.02
Enligt McKesson Corporation senaste finansiella rapporter och aktiekurs är det aktuella P/E-talet (TTM) 26.02. I slutet av 2024 hade företaget ett P/E-tal på 23.80.
Historik för P/E-tal för McKesson Corporation från 2000 till 2026
P/E-tal vid slutet av varje år
| År | P/E-tal | Ändra |
|---|---|---|
| 2026 (TTM) | 26.02 | 0.00% |
| 2025 | 26.02 | 9.31% |
| 2024 | 23.80 | 68.68% |
| 2023 | 14.11 | -66.28% |
| 2022 | 41.85 | -706.47% |
| 2021 | -6.90 | -125.37% |
| 2020 | 27.20 | -96.04% |
| 2019 | 686.13 | 56.89% |
| 2018 | 437.33 | 6,817.88% |
| 2017 | 6.32 | -60.53% |
| 2016 | 16.02 | -54.95% |
| 2015 | 35.55 | 11.06% |
| 2014 | 32.01 | 68.89% |
| 2013 | 18.96 | 23.18% |
| 2012 | 15.39 | -14.73% |
| 2011 | 18.05 | 28.94% |
| 2010 | 14.00 | 19.55% |
| 2009 | 11.71 | -23.94% |
| 2008 | 15.39 | -15.02% |
| 2007 | 18.12 | -16.19% |
| 2006 | 21.61 | -130.58% |
| 2005 | -70.69 | -623.74% |
| 2004 | 13.50 | 3.94% |
| 2003 | 12.99 | -49.58% |
| 2002 | 25.75 | -116.43% |
| 2001 | -156.79 | -2,020.83% |
| 2000 | 8.16 | 0.00% |
P/E-tal för liknande företag eller konkurrenter
| Företag | P/E-tal | Skillnad i P/E-tal | Land |
|---|---|---|---|
| - | - |
US
|
|
| 34.08 | 30.96% |
US
|
|
| - | - |
US
|
|
| 45.62 | 75.31% |
AU
|
|
| 24.73 | -4.97% |
US
|
Hur man läser ett P/E-tal
P/E-talet (Price/Earnings) mäter förhållandet mellan ett företags aktiekurs och dess vinst per aktie.
Ett lågt men positivt P/E visar ett företag med hög vinst i förhållande till värderingen och kan vara undervärderat. Ett högt negativt (nära 0) P/E indikerar stora förluster.
Företag med P/E över 30 eller negativt ses ofta som "tillväxtaktier", vilket innebär att investerare förväntar sig tillväxt eller framtida lönsamhet.
Företag med positivt P/E under 10 ses som "värdeaktier" och är redan lönsamma men med begränsad tillväxtpotential.